227 related articles for article (PubMed ID: 12706940)
1. Obesity is associated with increased levels of circulating hepatocyte growth factor.
Rehman J; Considine RV; Bovenkerk JE; Li J; Slavens CA; Jones RM; March KL
J Am Coll Cardiol; 2003 Apr; 41(8):1408-13. PubMed ID: 12706940
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity.
Bell LN; Ward JL; Degawa-Yamauchi M; Bovenkerk JE; Jones R; Cacucci BM; Gupta CE; Sheridan C; Sheridan K; Shankar SS; Steinberg HO; March KL; Considine RV
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E843-8. PubMed ID: 16757549
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
[TBL] [Abstract][Full Text] [Related]
6. Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Heart Vessels; 2000; 15(3):105-11. PubMed ID: 11289497
[TBL] [Abstract][Full Text] [Related]
7. Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction.
Soeki T; Tamura Y; Shinohara H; Sakabe K; Onose Y; Fukuda N
Circ J; 2002 Nov; 66(11):1003-7. PubMed ID: 12419930
[TBL] [Abstract][Full Text] [Related]
8. Increased angiogenic growth factor in cyanotic congenital heart disease.
Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.
Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Matsuzaki T; Takayama M; Shinmura K; Yamada M
Br J Ophthalmol; 1999 Jul; 83(7):834-7. PubMed ID: 10381671
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
[TBL] [Abstract][Full Text] [Related]
12. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
Reisinger K; Kaufmann R; Gille J
J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
[TBL] [Abstract][Full Text] [Related]
13. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
[TBL] [Abstract][Full Text] [Related]
14. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.
Ohno T; Yuge T; Kariyazono H; Igarashi H; Joh-o K; Kinugawa N; Kusuhara K; Hara T
Eur J Pediatr; 2002 Feb; 161(2):105-11. PubMed ID: 11954744
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
17. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
18. Activated human neutrophils release hepatocyte growth factor/scatter factor.
McCourt M; Wang JH; Sookhai S; Redmond HP
Eur J Surg Oncol; 2001 Jun; 27(4):396-403. PubMed ID: 11417987
[TBL] [Abstract][Full Text] [Related]
19. Evidence for association of coronary sinus levels of hepatocyte growth factor and collateralization in human coronary disease.
Lenihan DJ; Osman A; Sriram V; Aitsebaomo J; Patterson C
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1507-12. PubMed ID: 12521946
[TBL] [Abstract][Full Text] [Related]
20. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Cardiology; 2000; 93(3):168-74. PubMed ID: 10965088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
